Abstract
Allogeneic and autologous bone marrow and blood cell transplants are increasingly used treatments for cancer and disorders of bone marrow and immune function. This is largely due to use of autotransplants to treat common diseases such as breast cancer. The use of blood cells alone for autotransplants was also a significant change in the past 5 years. The IBMTR and ABMTR continue to provide a unique resource for studying outcomes and trends in allogeneic and autologous bone marrow and blood cell transplants.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adolescent
-
Adult
-
Anemia, Aplastic / mortality
-
Anemia, Aplastic / therapy
-
Bone Marrow Transplantation* / mortality
-
Bone Marrow Transplantation* / statistics & numerical data
-
Female
-
Hematopoietic Stem Cell Transplantation* / mortality
-
Hematopoietic Stem Cell Transplantation* / statistics & numerical data
-
Hodgkin Disease / mortality
-
Hodgkin Disease / therapy
-
Humans
-
International Agencies
-
Leukemia / mortality
-
Leukemia / therapy
-
Lymphoma, Non-Hodgkin / mortality
-
Lymphoma, Non-Hodgkin / therapy
-
Male
-
Middle Aged
-
North America
-
Registries*
-
Survival Rate
-
Transplantation, Autologous
-
Transplantation, Homologous